OAC
CELZ icon

OMERS Administration Corp’s Creative Medical Technology CELZ Stock Holding History

OMERS Administration Corp’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,000
Closed -$57.3K – 1073
2024
Q1 		$57.3K Buy
+11,000
New +$51.2K ﹤0.01% 364

Other funds holding CELZ

AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

OMERS Administration Corp's CELZ Position: Q2 2024 in Review

OMERS Administration Corp sold out of Creative Medical Technology (CELZ) in Q2 2024, closing a stake of 11,000 shares — an estimated $57.3K sold.

OMERS Administration Corp first reported a position in CELZ in Q1 2024 and held it in 1 quarter. The position peaked at $57.3K in Q1 2024. 9 funds tracked by Wall St. Rank hold CELZ as of Q2 2024.

  • OMERS Administration Corp reported no remaining Creative Medical Technology position as of Q2 2024 after selling out during the quarter.
  • OMERS Administration Corp sold 11,000 Creative Medical Technology shares in Q2 2024, an estimated $57.3K.
  • OMERS Administration Corp first reported a position in Creative Medical Technology in Q1 2024 and held it in 1 quarter.
  • OMERS Administration Corp's Creative Medical Technology position peaked at $57.3K in Q1 2024.
  • 9 funds tracked by Wall St. Rank held Creative Medical Technology as of Q2 2024.

Based on OMERS Administration Corp's 13F filing for Q2 2024, filed 13 Aug 2024.